白塞病的免疫发病机制与治疗方式
本文为叙述性综述,通过文献检索总结白塞病(BD)的发病机制与当前治疗选择。BD被认为是遗传易感个体在外界触发因素下引起免疫激活的自身炎症性疾病,固有免疫与适应性免疫均参与发病,治疗针对固有免疫和适应性免疫中的异常环节、按器官受累和患者特征个体化。
要点
- GWAS数据显示HLA-B51、ERAP1、IL10和IL23R-IL12RB2多种基因多态性与BD易感性增加相关。
- 链球菌等细菌、失衡的微生物组或分子模拟可触发BD炎症。
- 固有免疫(TLR、中性粒细胞、NK细胞、γδ-T细胞)产生或反应性增加可能是BD发病的关键步骤。
核心结论
- 本文对BD的发病机制与治疗选择进行了广泛综述。
- BD的发病机制尚待阐明,被认为是遗传易感个体在外界触发因素下引起免疫激活并导致炎症症状的疾病。
研究设计与样本
- 本文为叙述性综述,通过文献检索撰写BD发病机制与当前治疗选择的综述。
主要发现
- GWAS数据显示多种基因多态性(HLA-B51、ERAP1、IL10和IL23R-IL12RB2)与BD易感性增加相关。
- 链球菌等细菌、失衡的微生物组或分子模拟可触发BD炎症。
- 固有免疫应答成分(TLR、中性粒细胞、NK细胞或γδ-T细胞)对这些触发因素产生增加或反应性增强,可能是BD发病的关键步骤。
- 除自身炎症反应增强外,有证据显示适应性免疫系统失调,包括Th1/Th2平衡紊乱、Th17细胞扩增以及调节性T细胞可能减少,导致促炎细胞因子过剩。
- 炎症导致典型临床表型,包括口生殖器溃疡、葡萄膜炎和皮肤病变。
临床怎么用
- 治疗针对固有免疫(中性粒细胞和γδ-T细胞)和适应性免疫系统(TNF-α、INF-γ、IL-1)中发现的异常,按器官受累制定并基于患者特征个体化。
局限性
- BD的发病机制尚待阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Behçet's disease (BD) is an auto-inflammatory disease, primarily characterized by recurrent painful mucocutaneous ulcerations. METHODS: A literature search was performed to write a narrative review into the pathogenesis and current treatment options of BD. RESULTS: The pathogenesis of BD remains to be elucidated, but is considered a genetically primed disease in which an external trigger causes immune activation resulting in inflammatory symptoms. GWAS data show an association between multiple genetic polymorphisms (HLA-B51, ERAP1, IL10 and IL23R-IL12RB2) and increased susceptibility to BD. Bacteria as streptococci, an unbalanced microbiome or molecular mimicry trigger the inflammation in BD. Increased production or responsiveness of pro-inflammatory components of the innate immune response (TLR, neutrophils, NK-cells or γδ T-cells) to these triggers may be a crucial step in the pathogenesis of BD. Additionally to an increased autoinflammatory response there is evidence of a dysregulated adaptive immune system, with a disturbed Th1/Th2 balance, expansion of Th17 cells and possibly a decrease in regulatory T cells, resulting in a surplus in pro-inflammatory cytokines. The inflammation causes a typical clinical phenotype including orogenital ulcerations, uveitis and skin lesions. Treatment is aimed at the aberrations found in the innate (neutrophils and γδ-T cells) and adaptive immune system (TNF-α, INF-γ, IL-1), directed at organ involvement and individualized based on patient characteristics. CONCLUSION: We presented an extensive review into the pathogenesis and treatment options of BD.
引用
- van der Houwen TB, van Hagen PM, van Laar JAM, et al. Immunopathogenesis of Behçet's disease and treatment modalities. Semin Arthritis Rheum. 2022. PMID: 35038644. doi:10.1016/j.semarthrit.2022.151956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。